We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.59B
1-Year Est. Return
39.81%
This Fund
S&P 500
This Quarter
Est. Return
-17.67%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$666M
AUM Growth
-$78.6M
(-11%)
Cap. Flow
+$47.8M
Cap. Flow
% of AUM
7.17%
Top 10 Holdings %
Top 10 Hldgs %
3.73%
Holding
1,985
New
628
Increased
360
Reduced
345
Closed
644
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Relay Therapeutics
RLAY
|
+$3.83M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$3M |
| 3 |
Teck Resources
TECK
|
+$2.87M |
| 4 |
MODV
ModivCare
MODV
|
+$2.67M |
| 5 |
Genpact
G
|
+$2.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.07M |
| 2 |
CHS
Chicos FAS, Inc.
CHS
|
+$2.68M |
| 3 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$2.45M |
| 4 |
Crane NXT
CXT
|
+$2.44M |
| 5 |
ATCO
Atlas Corp.
ATCO
|
+$2.27M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.12% |
| 2 | Technology | 15.11% |
| 3 | Consumer Discretionary | 12.76% |
| 4 | Industrials | 12.53% |
| 5 | Financials | 11.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Cogent Communications
CCOI
$497M
| $460K | 0.07% |
+7,568
| New | +$466K |
|
552
Chegg
CHGG
$103M
| $460K | 0.07% |
+24,493
| New | +$561K |
|
553
uniQure
QURE
$3.22B
| $459K | 0.07% |
+24,604
| New | +$391K |
|
554
Century Casinos
CNTY
$34M
| $458K | 0.07% |
63,674
+32,450
| +104% | +$303K |
|
|
EQC
555
DELISTED
Equity Commonwealth
EQC
| $458K | 0.07% |
+16,628
| New | +$449K |
|
|
NPTN
556
DELISTED
NEOPHOTONICS CORP
NPTN
| $458K | 0.07% |
29,094
+7,262
| +33% | +$111K |
|
557
Apogee Enterprises
APOG
$908M
| $456K | 0.07% |
11,616
+300
| +3% | +$12.8K |
|
558
MGP Ingredients
MGPI
$375M
| $456K | 0.07% |
4,551
+1,705
| +60% | +$160K |
|
559
Rackspace Technology
RXT
$1.24B
| $456K | 0.07% |
+63,535
| New | +$573K |
|
560
Diodes
DIOD
$4.84B
| $455K | 0.07% |
7,046
-10,682
| -60% | -$779K |
|
561
Silicon Laboratories
SLAB
$7.23B
| $455K | 0.07% |
+3,244
| New | +$454K |
|
|
LHCG
562
DELISTED
LHC Group LLC
LHCG
| $454K | 0.07% |
2,914
-3,291
| -53% | -$542K |
|
563
Global Ship Lease
GSL
$1.53B
| $453K | 0.07% |
27,400
-39,531
| -59% | -$871K |
|
564
V2X
VVX
$2.65B
| $452K | 0.07% |
13,515
-1,303
| -9% | -$46.1K |
|
565
Astronics
ATRO
$3.84B
| $449K | 0.07% |
52,948
-30,667
| -37% | -$277K |
|
566
Suburban Propane Partners
SPH
$1.17B
| $449K | 0.07% |
+29,416
| New | +$487K |
|
|
HZNP
567
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $448K | 0.07% |
5,612
-3,770
| -40% | -$357K |
|
568
Vivid Seats
SEAT
$85.4M
| $447K | 0.07% |
+2,990
| New | +$541K |
|
569
Empire State Realty Trust
ESRT
$836M
| $445K | 0.07% |
63,256
+46,209
| +271% | +$375K |
|
570
Lufax Holding
LU
$1.3B
| $444K | 0.07% |
+18,485
| New | +$429K |
|
571
Raymond James Financial
RJF
$34B
| $443K | 0.07% |
+4,955
| New | +$486K |
|
572
Carter's
CRI
$1.47B
| $442K | 0.07% |
6,277
+3,402
| +118% | +$274K |
|
573
FMC
FMC
$1.33B
| $442K | 0.07% |
4,130
+387
| +10% | +$47.3K |
|
574
Manchester United
MANU
$3.73B
| $442K | 0.07% |
+39,785
| New | +$515K |
|
575
PTC Therapeutics
PTCT
$6.12B
| $441K | 0.07% |
11,002
-13,162
| -54% | -$462K |
|
Similar funds
NCL
DG
VNT
SS
GWANC
LCM
LCM
FDCP
GSA Capital Partners's Q2 2022 Portfolio in Review
As of Q2 2022, GSA Capital Partners held 1,985 positions worth $666M, down 11% from $745M the previous quarter. Its ten largest holdings account for 3.7% of the portfolio.
GSA Capital Partners deployed $47.8M of net new capital in Q2 2022, opening 628 new positions and adding to 360 existing holdings. Its largest new stake was Relay Therapeutics: 178,593 shares worth $2.99M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Chicos FAS, Inc., an estimated $2.68M trimmed.
- GSA Capital Partners's largest Q2 2022 buy was Relay Therapeutics: 178,593 shares worth $2.99M.
- GSA Capital Partners added most to Genpact in Q2 2022, an estimated $2.6M increase.
- GSA Capital Partners's biggest Q2 2022 reduction was Chicos FAS, Inc., cutting an estimated $2.68M.
- GSA Capital Partners fully exited Amazon in Q2 2022, selling an estimated $3.07M.
- GSA Capital Partners's ten largest holdings make up 3.7% of its $666M portfolio in Q2 2022.
- GSA Capital Partners opened 628 new positions and closed 644 in Q2 2022.
- GSA Capital Partners's portfolio value fell 11% quarter-over-quarter to $666M.
Based on GSA Capital Partners's 13F filing for Q2 2022, filed 9 Aug 2022.